These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10804753)

  • 21. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
    Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
    Yüksel H; Yilmaz O; Kirmaz C; Aydoğdu S; Kasirga E
    Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitor utilization patterns in infants.
    Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
    Karateev AE; Murav'ev IuV; Radenska-Lopovok SG; Nasonova VA
    Klin Med (Mosk); 2003; 81(8):37-41. PubMed ID: 14520944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitor therapy: preliminary results of a therapeutic interchange program.
    Amidon PB; Jankovich R; Stoukides CA; Kaul AF
    Am J Manag Care; 2000 May; 6(5):593-601. PubMed ID: 10977467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omeprazole or misoprostol. Which works best for NSAID-induced ulcers?
    Gautam M; Por CP; Evans MF
    Can Fam Physician; 1998 Aug; 44():1629-31. PubMed ID: 9721418
    [No Abstract]   [Full Text] [Related]  

  • 31. [Proton pump blockers and their significance in gastroenterology].
    Dítĕ P; Prásek J
    Vnitr Lek; 1995 Aug; 41(8):549-54. PubMed ID: 7483340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lansoprazole.
    Med Lett Drugs Ther; 1995 Jul; 37(953):63-4. PubMed ID: 7603391
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug of the month. Lansoprazole (DakaR)].
    Scheen AJ
    Rev Med Liege; 1995 Mar; 50(3):133-4. PubMed ID: 7724943
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole.
    Nelson WW; Vermeulen LC; Geurkink EA; Ehlert DA; Reichelderfer M
    Arch Intern Med; 2000 Sep; 160(16):2491-6. PubMed ID: 10979061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omeprazole.
    Med Lett Drugs Ther; 1990 Mar; 32(813):19-21. PubMed ID: 2179694
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospective study of the long-term efficacy and safety of lansoprazole in patients with the Zollinger-Ellison syndrome.
    Jensen RT; Metz DC; Koviack PD; Feigenbaum KM
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():41-50, discussion 61-6. PubMed ID: 8490079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proton pump inhibitor for maintenance therapy of peptic ulcer].
    Yanai H; Tada M; Okita K
    Nihon Rinsho; 1992 Jan; 50(1):167-73. PubMed ID: 1311782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton-pump inhibition for acid-related disease.
    Holt S
    South Med J; 1991 Sep; 84(9):1078-87. PubMed ID: 1653998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New therapy of peptic ulcer].
    Harada T
    Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):386-9. PubMed ID: 7751774
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.
    Metz DC; Pisegna JR; Ringham GL; Feigenbaum K; Koviack PD; Maton PN; Gardner JD; Jensen RT
    Dig Dis Sci; 1993 Feb; 38(2):245-56. PubMed ID: 8425437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.